Back
Regeneron Pharmaceuticals Stock Predictions
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]
Sell
38
REGN
Regeneron Pharmaceuticals
Last Price:
$680.00
Seasonality Move:
-2.68%
7 Day Trial
ALL ACCESS PASS
$
7
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]Regeneron Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 23.1% based on the past 33 years of stock performance.
-
Regeneron Pharmaceuticals has risen higher in 21 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
-
Is Regeneron Pharmaceuticals Stock Undervalued?The current Regeneron Pharmaceuticals [REGN] share price is $687.80. The Score for REGN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Regeneron Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 23.1% based on the past 33 years of stock performance.
Regeneron Pharmaceuticals Stock Rating
Sell
38
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals overpriced?
-
Regeneron Pharmaceuticals has risen higher in 21 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
Regeneron Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com
52-Week Data
52-Week High:
1,211.20
52-Week Low:
666.25
Prediction Charts
Market Cap:
75.6B
Price in USD:
687.80
Volume:
1.1M
Beta:
0.95
Technical Analysis
SMA50:
743.42
SMA100:
895.70
SMA200:
957.85
52-Wk Change:
-26.31%
Stock Predictions
-
Is Regeneron Pharmaceuticals stock public?Yes, Regeneron Pharmaceuticals is a publicly traded company.
-
What is the Regeneron Pharmaceuticals stock quote today?The Regeneron Pharmaceuticals stock price is 687.80 USD today.
-
How to buy Regeneron Pharmaceuticals stock online?You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-30 | 708.04 | 702.59 | 708.97 | 700.42 |
| Dec-31 | 703.90 | 712.33 | 713.00 | 703.39 |
| Jan-2 | 720.86 | 715.19 | 726.81 | 711.92 |
| Jan-3 | 716.07 | 718.15 | 722.00 | 714.76 |
| Jan-6 | 715.00 | 716.26 | 733.69 | 713.75 |
| Jan-7 | 716.34 | 730.30 | 734.44 | 716.34 |
| Jan-8 | 728.04 | 733.59 | 743.28 | 725.60 |
| Jan-10 | 721.33 | 696.88 | 724.73 | 691.00 |
| Jan-13 | 669.24 | 716.90 | 717.37 | 666.25 |
| Jan-14 | 714.01 | 690.87 | 715.98 | 686.00 |
| Jan-15 | 700.61 | 703.43 | 712.60 | 698.20 |
| Jan-16 | 701.04 | 693.23 | 706.54 | 691.33 |
| Jan-17 | 705.34 | 681.58 | 707.48 | 680.89 |
| Jan-21 | 687.46 | 687.80 | 692.93 | 681.52 |
Regeneron Pharmaceuticals Earnings
Regeneron Pharmaceuticals Earnings Report: Per Share Regeneron Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Regeneron Pharmaceuticals Forecast Revenue Growth
Regeneron Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $1.74 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $4.58 per share.
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.